The inhibition of cholinesterase activity to reduce acetylcholine depletion is a major approved strategy for the treatment of AD; so, we first evaluated the effect of the synthesized tryptanthrin derivatives on cholinesterase activity. This evidence concerns the gene BCHE and Alzheimer disease.